1 Introduction Modified Vaccinia virus Ankara (MVA) is a highly relevant viral gene vector for pharmaceutical applications (Clever et al. 2024; DeMaria et al. 2021; Kaufman et al. 2009; Kennedy and Greenberg 2009; Tscherne et al. 2024). It is an essential tool for gene expression and vaccination due to its ability to introduce genetic material into host cells. However, it cannot complete its replication cycle in human cells (Albarnaz et al. 2023; Blanchard et al. 1998).